Form 4: Biomea Fusion Director Eric Aguiar Acquires Stock Options
SEC Form 4 Filing
Director Eric Aguiar acquired stock options in Biomea Fusion, Inc. on June 12, 2024.
Summary
- On June 12, 2024, Eric Aguiar, a director of Biomea Fusion, Inc., acquired 51,025 stock options with an exercise price of $4.63.
- The options vest in full upon the earlier of the one-year anniversary of the grant date or immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to continued service.
- Following the transaction, Aguiar directly owns 51,025 derivative securities.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing regarding stock option grants, and does not contain information that would significantly shift investor sentiment.
Industry Context
This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership by a company insider. Such filings are common and provide transparency to the market regarding insider transactions.
Stakeholder Impact
- The transaction may have a minor positive impact on shareholder confidence due to the director's increased stake in the company.
Key Dates
| Date | Description |
|---|---|
| 06/12/2024 | Date of the stock option transaction. |
| 06/11/2034 | Expiration date of the stock options. |
| 06/13/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.